Evolent Health Non-GAAP EPS of 0.04 misses by 0.30, revenue of 621.4M misses by 5.75M
| SVUIX Fund | USD 9.46 0.10 1.07% |
Slightly above 50% of Guggenheim Mid's investors are presently thinking to get in. The analysis of overall sentiment of trading Guggenheim Mid Cap mutual fund suggests that some investors are interested at this time. Guggenheim Mid's investing sentiment can be driven by a variety of factors including economic data, Guggenheim Mid's earnings reports, geopolitical events, and overall market trends.
Guggenheim |
Evolent Health Q3 results - Non-GAAP EPS misses by 0.30, revenue misses by 5.75M, with 621.4M in revenue
Read at seekingalpha.com
 |
Guggenheim Mid Fundamental Analysis
We analyze Guggenheim Mid's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Guggenheim Mid using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Guggenheim Mid based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Year To Date Return
Year To Date Return Comparative Analysis
Guggenheim Mid is currently under evaluation in year to date return among similar funds. Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.
Guggenheim Mid Cap Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Guggenheim Mid mutual fund to make a market-neutral strategy. Peer analysis of Guggenheim Mid could also be used in its relative valuation, which is a method of valuing Guggenheim Mid by comparing valuation metrics with similar companies.
Peers
Guggenheim Mid Related Equities
| JVMIX | John Hancock | 1.00 | ||||
| JVMAX | John Hancock | 0.99 | ||||
| JMVZX | Jpmorgan Mid | 0.96 | ||||
| FLPKX | Fidelity Low-priced | 0.93 | ||||
| VMVAX | Vanguard Mid-cap | 0.67 | ||||
| VMVIX | Vanguard Mid-cap | 0.66 | ||||
| FLPSX | Fidelity Low-priced | 1.02 | ||||
| JMVQX | Jpmorgan Mid | 1.24 | ||||
| JMVRX | Jpmorgan Mid | 1.25 |
Other Information on Investing in Guggenheim Mutual Fund
Guggenheim Mid financial ratios help investors to determine whether Guggenheim Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Guggenheim with respect to the benefits of owning Guggenheim Mid security.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |